Hybridization analysis of D4Z4 repeat arrays linked to FSHD
- 28 November 2006
- journal article
- research article
- Published by Springer Nature in Chromosoma
- Vol. 116 (2) , 107-116
- https://doi.org/10.1007/s00412-006-0080-6
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disease involving shortening of D4Z4, an array of tandem 3.3-kb repeat units on chromosome 4. These arrays are in subtelomeric regions of 4q and 10q and have 1–100 units. FSHD is associated with an array of 1–10 units at 4q35. Unambiguous clinical diagnosis of FSHD depends on determining the array length at 4q35, usually with the array-adjacent p13E-11 probe after pulsed-field or linear gel electrophoresis. Complicating factors for molecular diagnosis of FSHD are the phenotypically neutral 10q D4Z4 arrays, cross-hybridizing sequences elsewhere in the genome, deletions including the genomic p13E-11 sequence and part of D4Z4, translocations between 4q and 10q D4Z4 arrays, and the extremely high G + C content of D4Z4 arrays (73%). In this study, we optimized conditions for molecular diagnosis of FSHD with a 1-kb D4Z4 subfragment probe after hybridization with p13E-11. We demonstrate that these hybridization conditions allow the identification of FSHD alleles with deletions of the genomic p13E-11 sequence and aid in determination of the nonpathogenic D4Z4 arrays at 10q. Furthermore, we show that the D4Z4-like sequences present elsewhere in the genome are not tandemly arranged, like those at 4q35 and 10q26.Keywords
This publication has 62 references indexed in Scilit:
- Regulation of the human catalytic subunit of telomerase (hTERT)Gene, 2012
- Using detection of survivin‐expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancerJournal of Surgical Oncology, 2010
- Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survivalJournal of Translational Medicine, 2009
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Targeting survivin in cancer therapy: fulfilled promises and open questionsCarcinogenesis: Integrative Cancer Research, 2007
- Circulating tumor cells in breast cancer: Advanced tools for “tailored” therapy?Proceedings of the National Academy of Sciences, 2006
- Somatic mosaicism in FSHD often goes undetectedAnnals of Neurology, 2004
- Molecular organization and chromosomal location of human GC-rich heterochromatic blocksGene, 1993